Postdoctoral position in gene therapy
The Immunology and liver gene transfer team directed by Giuseppe Ronzitti in the INTEGRARE unit ("integrated genetic approaches for the treatment of rare genetic diseases", also identified as UMR_S951) of Genethon focuses on the development of AAV gene transfer strategies for rare genetic diseases.
The current project aims at the identification of new AAV capsid for in vivo gene transfer financed through the ''Plan de relance'' of the French government.
Fixed-term contract of 2 years, starting no later than October 1st, 2022.
The candidate should have discussed his/her PhD thesis not before 2019 and the salary is aligned with INSERM policy.
Previous experience in gene therapy is a plus, but not required.